🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Pacific Oncololgy & Hematology
Start Date
2009-06
Trial ID
NCT00920855
Treatments Being Tested
This is an open label, dose escalation, phase I study of the combination of...
Status
Withdrawn
Location
Dartmouth-Hitchcock Medical Center
Start Date
2016-08
Trial ID
NCT03422874
Treatments Being Tested
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048
Primary objective of the study is the determination of the maximum tolerate...
Status
Completed
Location
University Medical Center Freiburg
Start Date
2011-08
Trial ID
NCT01394354
Treatments Being Tested
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
The purpose of this study is to determine if Bortezomib, known commercially...
Status
Completed
Location
Spectrum Health
Start Date
2012-04
Trial ID
NCT01860170
In Phase I, patients will receive a combination of PS-341 (Velcade) and R11...
Status
Terminated
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2005-08
Trial ID
NCT00361088
The purpose of this study is determine the highest dose of bortezomib, a ne...
Status
Completed
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2008-05-16
Trial ID
NCT00670423
Treatments Being Tested
This is a Phase I/II trial designed to study the toxicity and Maximum Toler...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2006-04-14
Trial ID
NCT00571493
Treatments Being Tested
This study is researching an experimental drug called linvoseltamab in comb...
Status
Recruiting
Location
Scripps Clinic Torrey Pines
Start Date
2022-08-17
Trial ID
NCT05137054